Cleared Special

K040435 - ROCHE DIAGNOSTICS TINA-QUANT IGA GEN.2 (FDA 510(k) Clearance)

Mar 2004
Decision
20d
Days
Class 2
Risk

K040435 is an FDA 510(k) clearance for the ROCHE DIAGNOSTICS TINA-QUANT IGA GEN.2. This device is classified as a Iga, Antigen, Antiserum, Control (Class II - Special Controls, product code CZP).

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on March 10, 2004, 20 days after receiving the submission on February 19, 2004.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5510.

Submission Details

510(k) Number K040435 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2004
Decision Date March 10, 2004
Days to Decision 20 days
Submission Type Special
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code CZP — Iga, Antigen, Antiserum, Control
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5510